Clinical Trials Browser

OTHER × Lung Neoplasms × ibrutinib × Clear all

NCT02321540 2023-10-25

A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer

Phase 1/2 Completed

13 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms